<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4CB92F40-4E51-4027-B354-8C9737DBBCAD"><gtr:id>4CB92F40-4E51-4027-B354-8C9737DBBCAD</gtr:id><gtr:name>University of Tromsoe</gtr:name><gtr:address><gtr:line1>Arctic University of Norway</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Norway</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EF304075-C803-45F8-8F68-0CC2B0BE0135"><gtr:id>EF304075-C803-45F8-8F68-0CC2B0BE0135</gtr:id><gtr:name>Osaka University</gtr:name><gtr:address><gtr:line1>1-1 Yamadaoka Suita</gtr:line1><gtr:postCode>565 0871</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/04500B3A-1219-4E25-96B6-5AFBA5839CAA"><gtr:id>04500B3A-1219-4E25-96B6-5AFBA5839CAA</gtr:id><gtr:name>French National Institute of Agricultural Research</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AFCF678A-5FC2-4D86-B376-12C1457C0F14"><gtr:id>AFCF678A-5FC2-4D86-B376-12C1457C0F14</gtr:id><gtr:name>Columbia University Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/621CACAB-53EE-48C8-A5EF-69DA4FA58943"><gtr:id>621CACAB-53EE-48C8-A5EF-69DA4FA58943</gtr:id><gtr:name>Leibniz Association</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4CB92F40-4E51-4027-B354-8C9737DBBCAD"><gtr:id>4CB92F40-4E51-4027-B354-8C9737DBBCAD</gtr:id><gtr:name>University of Tromsoe</gtr:name><gtr:address><gtr:line1>Arctic University of Norway</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Norway</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EF304075-C803-45F8-8F68-0CC2B0BE0135"><gtr:id>EF304075-C803-45F8-8F68-0CC2B0BE0135</gtr:id><gtr:name>Osaka University</gtr:name><gtr:address><gtr:line1>1-1 Yamadaoka Suita</gtr:line1><gtr:postCode>565 0871</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/04500B3A-1219-4E25-96B6-5AFBA5839CAA"><gtr:id>04500B3A-1219-4E25-96B6-5AFBA5839CAA</gtr:id><gtr:name>French National Institute of Agricultural Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AFCF678A-5FC2-4D86-B376-12C1457C0F14"><gtr:id>AFCF678A-5FC2-4D86-B376-12C1457C0F14</gtr:id><gtr:name>Columbia University Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/621CACAB-53EE-48C8-A5EF-69DA4FA58943"><gtr:id>621CACAB-53EE-48C8-A5EF-69DA4FA58943</gtr:id><gtr:name>Leibniz Association</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A5F8D5AA-D03C-41D8-88B2-6EB775FF2C66"><gtr:id>A5F8D5AA-D03C-41D8-88B2-6EB775FF2C66</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:surname>Ktistakis</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A8FFE8BD-0636-4C9D-A5F7-29460A47D865"><gtr:id>A8FFE8BD-0636-4C9D-A5F7-29460A47D865</gtr:id><gtr:firstName>Len</gtr:firstName><gtr:surname>Stephens</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C0A7056F-E319-488D-BC7B-EB4514B543F8"><gtr:id>C0A7056F-E319-488D-BC7B-EB4514B543F8</gtr:id><gtr:firstName>Simon</gtr:firstName><gtr:otherNames>Jonathan</gtr:otherNames><gtr:surname>Cook</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2B0F97E4-31D8-4D0A-9F3D-BCBF30B574C5"><gtr:id>2B0F97E4-31D8-4D0A-9F3D-BCBF30B574C5</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Wakelam</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/489B2175-D1F8-479D-87B2-2C791677D905"><gtr:id>489B2175-D1F8-479D-87B2-2C791677D905</gtr:id><gtr:firstName>Phillip</gtr:firstName><gtr:surname>Hawkins</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BBS%2FE%2FB%2F000C0413"><gtr:id>A4B2D416-535B-4E36-9210-29BE964E2A22</gtr:id><gtr:title>To map the organisation of nutrient signalling pathways</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>BBS/E/B/000C0413</gtr:grantReference><gtr:abstractText>We propose to begin to characterize the responses of freshly-prepared, collagenase-liberated isolated mouse hepatocytes to a range of specific nutrient challenges, that cannot be applied in vivo, in terms of their effect on the class I &amp;amp; III PI3K pathways to mTor, mTor activity, the intiation of autophagy and ROS production. So that in the second half of the project we can look at aged and diet-restricted animals. We aim to publish our first major study indicating that amino acids controlling mTor activity are taken-up by macro-pinocytosis and to have advanced our work addressing the nature of the Ca2+ signals controlling mTor at lysosomes near to a point of submission. We will have tested several amino acid analogues for their effect on mTORC1 activation and then image their distribution within cells. A project following-up the confirmed hits from our genome-wide screens for suppressors and activators of vps34 complexes in autophagy. This work will focus on specific hypotheses arising from that work using a combination of molecular, cell biology and systems approaches to assemble subsets of hits into meaningful regulatory networks. Within that project we aim to have isolated the subset of hits that appear to affect mTORC1 localization and activity and begun to generate a signalling diagram leading from starvation to autophagy. We will have begun to analyse the products of DAz-2 derivatised cell lysates to reveal the complexity of the samples we will be attempting to analyse. Following on from our new data we will define the activation status of ERK1/2, p38, MNK1/2 and eIF4E during nutrient starvation and during acute and chronic mTOR inhibition in primary human fibroblasts and assess their activation in young and aged fibroblasts. This will be a pre-requisite to gene expression studies and analysis of young and aged samples.</gtr:abstractText><gtr:fund><gtr:end>2017-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2012-04-01</gtr:start><gtr:type>EXPENDITURE_PROJECTED</gtr:type><gtr:valuePounds>3580156</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Columbia University Medical Center</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Parsons - PREX</gtr:description><gtr:id>620DEBB0-9E0A-4950-B765-6900C3847F3A</gtr:id><gtr:impact>Hodakoski et al (2014) Proc Natl Acad Sci U S A. 111(1):155-60. doi: 10.1073/pnas.1213773111. Epub 2013 Dec 23.</gtr:impact><gtr:outcomeId>5461faab0cf6a9.22517692-1</gtr:outcomeId><gtr:partnerContribution>Intellectual frame work for study and biological material</gtr:partnerContribution><gtr:piContribution>Analysis of phosphoinositides by mass spectrometry</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Tromso</gtr:collaboratingOrganisation><gtr:country>Norway, Kingdom of</gtr:country><gtr:department>Department of Medical Biology</gtr:department><gtr:description>p62 phosphorylation</gtr:description><gtr:id>D1327A1C-612D-4818-B7C6-0CDD0B45BD63</gtr:id><gtr:impact>Too soon for any specific outputs as the collaboration has only just started. However, i have visited the University of Tromso and presented two Lectures as part of a PhD training course</gtr:impact><gtr:outcomeId>58c6c504963577.81484997-1</gtr:outcomeId><gtr:partnerContribution>Terje Johansen's lab will share reagents and expertise and perform specific experiments to define the interaction between DYRKs and p62</gtr:partnerContribution><gtr:piContribution>Sharing of data; discussion of new experimental directions; experiments
We have identified p62/SQSTM1 as a novel substrate of DYRK1B and DYRK2. We are investigating the role of this phosphorylation on p62 functions in proteostasis, stress responses and nutrient signalling</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Southampton</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Divecha</gtr:description><gtr:id>54BEAA40-02BB-4BB4-995E-660D7442A9F8</gtr:id><gtr:impact>Multi-disciplinary, we do lipidomics and mouse work.
They do cell line experiments and cancer related experiments</gtr:impact><gtr:outcomeId>58c69a280a2391.53359734-1</gtr:outcomeId><gtr:partnerContribution>Preparation of cell extracts</gtr:partnerContribution><gtr:piContribution>Measurement of phosphoinositides. GM mouse projects progressed.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCL Cancer Institute</gtr:department><gtr:description>Van haesebroeck - PI3K</gtr:description><gtr:id>E1B87584-D726-47A1-99E7-6618E48DBFF0</gtr:id><gtr:impact>Alliouachene et al (2015) Cell Rep. 13(9):1881-94. doi: 10.1016/j.celrep.2015.10.052
Gyori et al (2014) Arthritis Rheumatol. 66(8):2210-21. doi: 10.1002/art.38660.
Kulkarni et al (2011) Sci Signal. 4(168):ra23. doi: 10.1126/scisignal.2001617.</gtr:impact><gtr:outcomeId>5461fbab3cb0a9.76071609-1</gtr:outcomeId><gtr:partnerContribution>Intellectual input, biological samples. Wide ranging collaboration covering several projects.</gtr:partnerContribution><gtr:piContribution>Intellectual input, reagents and mass spectrometric analysis of phosphoinositides</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>French National Institute of Agricultural Research</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>INRA laboratory Toxalim</gtr:department><gtr:description>Herve Gillou</gtr:description><gtr:id>DFE99256-44B3-44DA-8BE4-455392EF6193</gtr:id><gtr:impact>Multi-discipllinary, We perform lipidomics , 
Toulouse group deal with mouse models and diet manipulation</gtr:impact><gtr:outcomeId>58c6907219cdd0.48285372-1</gtr:outcomeId><gtr:partnerContribution>Preparation of cell samples, dietary manipulation of mice, eg high fat diet</gtr:partnerContribution><gtr:piContribution>Measurements of Phosphosphoinositides</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Pathology</gtr:department><gtr:description>Irvine_PI5P4K alpha</gtr:description><gtr:id>B867F2AD-E55F-48B7-9330-555444E0EF01</gtr:id><gtr:impact>Bulley SJ, Droubi A, Clarke JH, Anderson KE, Stephens LR, Hawkins PT, Irvine RF.
Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):10571-6. doi: 10.1073/pnas.1522478113.</gtr:impact><gtr:outcomeId>58b441ca496686.73871252-1</gtr:outcomeId><gtr:partnerContribution>They designed the study and provided biological material</gtr:partnerContribution><gtr:piContribution>We measured phosphoinositides by mass spectrometry</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Osaka University</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>Tamotsu</gtr:description><gtr:id>72D22082-7AD1-445E-B78E-0FF95EAA4A7A</gtr:id><gtr:impact>Published 2 papers together</gtr:impact><gtr:outcomeId>5460a9f5068bf0.42108660-1</gtr:outcomeId><gtr:partnerContribution>Papers together</gtr:partnerContribution><gtr:piContribution>Papers together</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Laboratory of Molecular Biology (LMB)</gtr:department><gtr:description>Roger Williams</gtr:description><gtr:id>B7BC64F1-1EB8-441B-84EF-2088F735EAE8</gtr:id><gtr:impact>Publications and grants</gtr:impact><gtr:outcomeId>56d6b6f1caa642.71483398-1</gtr:outcomeId><gtr:partnerContribution>Exchange of reagents and cell lines</gtr:partnerContribution><gtr:piContribution>Exchange of reagents and cell lines</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leibniz Association</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Leibniz-Institute for Molecular Pharmacology</gtr:department><gtr:description>Volker Haucke</gtr:description><gtr:id>04FDC2F3-32DB-40E1-8FBB-B16568746B7D</gtr:id><gtr:impact>Multi-disciplinary, high content imaging, mass spectrometry, biochemisty</gtr:impact><gtr:outcomeId>58c679bc5aeaf5.69170483-1</gtr:outcomeId><gtr:partnerContribution>They have established assays of intracellualr trafficking using high content imaging technology and to measure mTOR1 distribution and roles.</gtr:partnerContribution><gtr:piContribution>Measurements of phopshoinositides and advice about assays for inostiol phosphates</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Southampton</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Primary Care and Population Sciences</gtr:department><gtr:description>Divecha - phosphoinositides</gtr:description><gtr:id>D2867BDF-610A-4832-BD57-36CF365A33E1</gtr:id><gtr:impact>Stijf-Bultsma et al (2015) Mol Cell. 58(3):453-67. doi: 10.1016/j.molcel.2015.03.009.
Jones et al (2015) FEBS 281(16):3591-608. doi: 10.1111/febs.12879.</gtr:impact><gtr:outcomeId>5461f5a387a758.77751050-1</gtr:outcomeId><gtr:partnerContribution>Intellectual framework for study, biological samples</gtr:partnerContribution><gtr:piContribution>expertise, reagents, measurements of phosphoinositides by mass spectrometry</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>AstraZeneca mTOR</gtr:description><gtr:id>652D12D5-27A6-45D3-B819-EBFE5B64745E</gtr:id><gtr:impact>The PhD student successfully completed their PhD, two papers have been published and additional work is ongoing.</gtr:impact><gtr:outcomeId>56c340cc59ad52.32361337-1</gtr:outcomeId><gtr:partnerContribution>Our partners at AstraZeneca part funded a BBSRC PhD student to do this work, provided large quantities of mTOR inhibtor as an 'in kind' contribution and performed next gen sequencing and other analyses of resistant cells to probe for mechanisms of resistance</gtr:partnerContribution><gtr:piContribution>Inhibitors of mTOR promote healthy lifespan extension in model organisms by promoting autophagy and are also undergoing evaluation as a treatment for cancer. However, complete mTOR inhibition is not compatible with life. We are interested in how the mTOR pathway is remodelled during chronic exposure to mTOR inhibitors. We have generated cells that are resistant to mTOR inhibitors and examined the mTOR pathway to identify changes that underpin resistance.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Dundee</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Doreen Cantrell</gtr:description><gtr:id>1BF3D62A-3FE2-49FB-A36F-BFD0EE748975</gtr:id><gtr:impact>Publications that are fully reported</gtr:impact><gtr:outcomeId>56b0d6d2193c30.04331327-1</gtr:outcomeId><gtr:partnerContribution>Samples of lymphocytes</gtr:partnerContribution><gtr:piContribution>Measurements of phosphoinositides</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Invited lecturer to international meetings (average 2-3 per year)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5B4AB693-2607-4CFE-A6DB-771702230A5D</gtr:id><gtr:impact>promoted discussions, collaborations

scientific collaborations, joint grants and publications</gtr:impact><gtr:outcomeId>546215ce564be0.43637759</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>Pre-2006,2006,2007,2008,</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visits by Teachers</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A0A4532B-B2A2-42BC-861C-C56FC878F904</gtr:id><gtr:impact>I hosted two 6th form Biology teachers (one PhD trained, the other MSc trained) who were visiting my Institution during Half Term to update their knowledge as part of their CPD</gtr:impact><gtr:outcomeId>56c1e8c3788c99.07519338</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>527BB254-687A-494A-B6DD-67ACF78BA949</gtr:id><gtr:impact>Students visited the lab and undertook small lab-based proejcts supervised by students/post-docs and myself. I explained the research that we do and discussed ethical issues such as the use of animals in research.
This precipitated excellent discussion and dialogue.

We received excellent feedback from the schools involved and requests for further outreach activities</gtr:impact><gtr:outcomeId>546f1146bc7243.35670753</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013,2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Hellenic Learned Society</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A8B8A63D-3AAA-4256-95F8-CE8A05DE4371</gtr:id><gtr:impact>President of Society of Greek and Cypriot academics in Cambridge, charged with organizing events with well-known speakers in the fields of Science of Humanities and addressed to a lay/educated audience. So far we have organized 7 such events with average attendance of 90 people.</gtr:impact><gtr:outcomeId>56d6b3ba7c58a1.59998946</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://camlearnhelsoc.wordpress.com/</gtr:url><gtr:year>2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Enterprise &amp; Technology Club</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>33CA1C3B-65E6-43C7-94EE-A74877048E4A</gtr:id><gtr:impact>Talk on autophagy and degenerative diseases</gtr:impact><gtr:outcomeId>56d6b476773f69.11163655</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.cetc.info/degenerative-diseases/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Development strategy council</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E7EFB959-D7AD-45D9-9483-EDCC9BF7688E</gtr:id><gtr:impact>Part of an international panel of experts convened by the Greek Economic Ministry to help develop Biotech industries in Greece</gtr:impact><gtr:outcomeId>58c6b6465aa376.22733525</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>In conversation with the Babraham Institute - part of Cambridge Science Festival</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>E60D99D1-4A9E-4055-953A-4AB6DE723D6F</gtr:id><gtr:impact>1:1 dialogue with general public (open invitation but registration required for numbers). 
Evening reception in which we explain our science and answer questions
Part of a programme of events for the annual Cambridge Science Festival</gtr:impact><gtr:outcomeId>58c6c8ec91ae08.38724308</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public feedback exercise</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>D52C2272-6107-48E6-B87D-40E8C38F1894</gtr:id><gtr:impact>The Signalling Department, in parallel with other BI departments, presented our research to a professionally selected sample of the UK public with the interntion of gaining public feedback on our institute and research.</gtr:impact><gtr:outcomeId>56b883af3884f0.51484512</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Reagents and assays developed have been used to set up a screening platform for identification of novel autophagy modulators. This has been funded by the Institute and is using a chemical library provided by MRC-T.
We have also generated immortalised human cell lines that have adapted to chronic mTOR inhibition (which mimics nutrient starvation) and investigated the underlying mechanisms of adaptation. These cell lines have been made available to other academics and industrial collaborators. For example, AstraZeneca are developing mTOR inhibitors for the treatment of malignancy and are interested in how cells adapt and acquires resistance to such drugs and this will help them to maximise drug efficacy and identify patient populations most likely to respond.</gtr:description><gtr:firstYearOfImpact>2014</gtr:firstYearOfImpact><gtr:id>13D95864-1753-4879-B8C5-B0C77834BF4C</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56d6be12e0b150.84460227</gtr:outcomeId><gtr:sector>Education,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>In collaboration with MISSION Therapeutics the PhD student has screened and identified DUBs that determine whether ERK pathway or mTOR inhibition leads ot cell death or not. These might be potential drug targets</gtr:description><gtr:grantRef>BBS/E/B/000C0413</gtr:grantRef><gtr:id>89E8BAB9-4EBF-4581-BB1B-81E3452F5395</gtr:id><gtr:impact>Too early for direct impacts. Further validation and characterisation required</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:outcomeId>58c7c6252a39a6.70431759</gtr:outcomeId><gtr:protection>Protection not required</gtr:protection><gtr:title>Identification of Deubiquitylating enzymes that arbitrate cell death in response ot ERK pathway or mTOR inhibition</gtr:title><gtr:yearProtectionGranted>2017</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Identification of genes/enzymes driving acquired resistance to mTOR inhibitors - these are possibly druggable targets for overcoming acquired resistance</gtr:description><gtr:grantRef>BBS/E/B/000C0413</gtr:grantRef><gtr:id>4F7DE1B9-EC7D-4D9E-B8F3-2A78DAE17B54</gtr:id><gtr:impact>Too early to say but these genes/enzymes are possibly druggable targets for overcoming acquired resistance</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>56c3519aa855f0.09997526</gtr:outcomeId><gtr:protection>Protection not required</gtr:protection><gtr:title>Identification of genes/enzymes driving resistance to mTOR inhibitors</gtr:title></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:keyFindingsOutput><gtr:description>mTOR is a master regulator of nutrient status. In organisms as diverse as worms, flies, mice and men it coordinates how cells respond to changes in nutrient availability. In addition, drugs that inhibit mTOR can mimic nutrient starvation and increase lifespan in several organisms and can make longer lived organisms healthier (increasing their healthspan).
We discovered how mTOR, an important kinase that regulates autophagy, traffics on and off lysosomes in response to amino acids. 
We also discovered how the earliest autophagy intermediate looks like by combining live imaging and super resolution microscopy. 
In addition we have discovered one mechanism by which cells are able to adapt to long-term inhibition of mTOR. This may be relevant to models of lifespan/healthspan extension and also to possible therapeutic uses of mTOR inhibitors.</gtr:description><gtr:exploitationPathways>The dynamics of the processes that we described can be analyzed in neuronal cells undergoing neurodegeneration, or in cells as they age, in order to assay the benefits of potential drugs. Indeed, understanding how cells adapt to long-term mTOR inhibition will be important to pharmaceutical companies seeking to develop mTOR inhibitors of treatment of disease</gtr:exploitationPathways><gtr:id>9198454C-3B67-4EE5-8D54-DDA3FDFBED15</gtr:id><gtr:outcomeId>56d6bfc1de2823.92393464</gtr:outcomeId><gtr:sectors><gtr:sector>Education,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of Scientific Advisory Board of Cancer Research Technology Discovery Lab</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>18566555-14E4-4708-8528-786596021379</gtr:id><gtr:outcomeId>58c7ba68ae98d8.97108955</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>In collaboration with MISSION Therapeutics we have undertaken an RNAi screen with human deubiquitylating enzymes (DUBs) to identify those DUBs that confer protection against ERK pathway, mTOR inhibition or PERK inhibition
Datat is currently being analysed before candidates are selected for further characterisation</gtr:description><gtr:id>815C1BA4-9472-4F86-89BA-2D40F70C36E9</gtr:id><gtr:impact>Too early for impacts
This data will be made available to the community in the future</gtr:impact><gtr:outcomeId>58c7ab157de279.78009312</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>DUB RNAi screen</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have generated HCT116 cell lines lacking one or other or both (DKO) of the critical NFkB activating protein kinases IKKalpha or IKKbeta using CRISPR/Cas9 gene targeting.</gtr:description><gtr:id>C3D2A234-14C6-4B61-B574-0173A90DB7FF</gtr:id><gtr:impact>Too early for impacts; cells still being charatcerised.
These will be made available to the community in the future</gtr:impact><gtr:outcomeId>58c7a9eca0fa27.74525116</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>IKKalpha and IKKbeta KO cell lines</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>HEK293 cells lines engineered to exhibit Tet-inducible expression of the DYRK2 protein kinase</gtr:description><gtr:id>5820114A-7C05-4690-A117-9C17ABCC528F</gtr:id><gtr:impact>New knowledge of DYRK2
Identification of new substrates of DYRK2</gtr:impact><gtr:outcomeId>58c6cb51503056.35567971</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Inducible DYRK2 cell line</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have generated human cell lines (cancer cells and primary human fibroblasts) with adaptive resistance to the mTOR inhibitors rapamycin and AZD8055</gtr:description><gtr:id>C9BCD216-6D57-49AD-B1AC-700762F0BBA0</gtr:id><gtr:impact>Two papers have been published and this has provided insight in to likely mechanisms by which cancer cells may adapt and acquire resistance to mTOR inhibitors</gtr:impact><gtr:outcomeId>56c34733c8e629.16611224</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>mTORi resistant cell lines</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>DCA96238-FE22-4B5B-A915-74C53045CA71</gtr:id><gtr:title>C13orf31 (FAMIN) is a central regulator of immunometabolic function.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32711005bbbc3c895889b86f934b0688"><gtr:id>32711005bbbc3c895889b86f934b0688</gtr:id><gtr:otherNames>Cader MZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>58c7b47f53ed56.88429662</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5ED8CDB5-2E91-4C11-818A-883C71E5BFEC</gtr:id><gtr:title>Assembly of early machinery for autophagy induction: novel insights from high resolution microscopy.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a519bc60c52f404fb7358caee74f1e3"><gtr:id>8a519bc60c52f404fb7358caee74f1e3</gtr:id><gtr:otherNames>Ktistakis NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>58c6c024dac0d5.76619769</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C3AFC30-72D1-4A13-8410-241A7CFF9C4C</gtr:id><gtr:title>Imaging autophagy.</gtr:title><gtr:parentPublicationTitle>Current protocols in cytometry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58ff07c4c65556081b629ab8ffec8226"><gtr:id>58ff07c4c65556081b629ab8ffec8226</gtr:id><gtr:otherNames>Karanasios E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1934-9297</gtr:issn><gtr:outcomeId>54648682000f16.46342432</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C4172EE-03EF-4E45-8741-779370F6EC97</gtr:id><gtr:title>Adaptation to chronic mTOR inhibition in cancer and in aging.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78262698bd2c49ee0e8ffdae19911d01"><gtr:id>78262698bd2c49ee0e8ffdae19911d01</gtr:id><gtr:otherNames>Gilley R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>546f51098da9a4.71087295</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72966C50-5D4A-4893-9A6A-4306B5699A58</gtr:id><gtr:title>Deciphering lipid structures based on platform-independent decision rules.</gtr:title><gtr:parentPublicationTitle>Nature methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1b2a00e5bc3ace2b0375d17d3e62ac9"><gtr:id>b1b2a00e5bc3ace2b0375d17d3e62ac9</gtr:id><gtr:otherNames>Hartler J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1548-7091</gtr:issn><gtr:outcomeId>5a840bc1a693c5.22641982</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>757B35FD-805B-4599-AC61-560D92CA5167</gtr:id><gtr:title>Control of cell death and mitochondrial fission by ERK1/2 MAP kinase signalling.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d9a51fb590ce42722d2925380aa98f5"><gtr:id>3d9a51fb590ce42722d2925380aa98f5</gtr:id><gtr:otherNames>Cook SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>5a2faee6dec678.71936775</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7850BC40-C4FF-47B3-BE2F-BBF5311779D5</gtr:id><gtr:title>Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3338e204a3c58e1fab88cb3342a71645"><gtr:id>3338e204a3c58e1fab88cb3342a71645</gtr:id><gtr:otherNames>Klionsky DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>58c6c02530ea12.82943074</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>256D0F88-8D0E-48EF-B1FF-3A38762B023F</gtr:id><gtr:title>Digesting the Expanding Mechanisms of Autophagy.</gtr:title><gtr:parentPublicationTitle>Trends in cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a519bc60c52f404fb7358caee74f1e3"><gtr:id>8a519bc60c52f404fb7358caee74f1e3</gtr:id><gtr:otherNames>Ktistakis NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0962-8924</gtr:issn><gtr:outcomeId>585d4152059cb4.53853994</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9705D4E4-4D64-4AFA-8936-4DE3EDFA6813</gtr:id><gtr:title>SGK1 Is a Critical Component of an AKT-Independent Pathway Essential for PI3K-Mediated Tumor Development and Maintenance.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c736fdd6ae6b58be2ae4981926d26dd1"><gtr:id>c736fdd6ae6b58be2ae4981926d26dd1</gtr:id><gtr:otherNames>Orlacchio A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>5a8af658b01ae4.53677276</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20055D55-1C7D-4D32-9384-0782FE846BC0</gtr:id><gtr:title>Characterization of Atg38 and NRBF2, a fifth subunit of the autophagic Vps34/PIK3C3 complex.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e550cedc0981a774e7e4c1b3300448fd"><gtr:id>e550cedc0981a774e7e4c1b3300448fd</gtr:id><gtr:otherNames>Ohashi Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>58c6c024335154.31156726</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>346F06FE-1D0F-4E3A-9816-D319221E27CB</gtr:id><gtr:title>PI3K signalling: the path to discovery and understanding.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Molecular cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e8ef3720a283f60669bc6948866244e"><gtr:id>6e8ef3720a283f60669bc6948866244e</gtr:id><gtr:otherNames>Vanhaesebroeck B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-0072</gtr:issn><gtr:outcomeId>doi_55f94d94d60d10de</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8578AFCE-B2F9-45BB-A6E0-5F4AA16C168A</gtr:id><gtr:title>Omegasomes: PI3P platforms that manufacture autophagosomes.</gtr:title><gtr:parentPublicationTitle>Essays in biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/153d298e7ae040a24d02d71586e4b42b"><gtr:id>153d298e7ae040a24d02d71586e4b42b</gtr:id><gtr:otherNames>Roberts R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0071-1365</gtr:issn><gtr:outcomeId>54648681a90df0.82708848</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB5530E6-B0D5-4490-9CAA-CEA08592216C</gtr:id><gtr:title>Differential isolation and identification of PI(3)P and PI(3,5)P2 binding proteins from Arabidopsis thaliana using an agarose-phosphatidylinositol-phosphate affinity chromatography.</gtr:title><gtr:parentPublicationTitle>Journal of proteomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75f0f8b6e431d12f74bef41bb47d27cf"><gtr:id>75f0f8b6e431d12f74bef41bb47d27cf</gtr:id><gtr:otherNames>Oxley D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1874-3919</gtr:issn><gtr:outcomeId>546486815f2454.18548159</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B003C64E-03F9-4FC4-BF60-275DF794FDD9</gtr:id><gtr:title>Lysophosphatidylinositol-acyltransferase-1 (LPIAT1) is required to maintain physiological levels of PtdIns and PtdInsP(2) in the mouse.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b69f958d0a381f3030849518250d3521"><gtr:id>b69f958d0a381f3030849518250d3521</gtr:id><gtr:otherNames>Anderson KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5463715eed0fc3.36320995</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A3BC54D-601C-4E70-A7B0-FED0BBEDDFD2</gtr:id><gtr:title>Two distinct functions for PI3-kinases in macropinocytosis.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb420bd904ae8b3d16b8ade3fa4a6d22"><gtr:id>fb420bd904ae8b3d16b8ade3fa4a6d22</gtr:id><gtr:otherNames>Hoeller O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>5463715f1f21d5.44904050</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AB3A298-7E1F-4E9A-8427-B901B5E19859</gtr:id><gtr:title>Signaling via class IA Phosphoinositide 3-kinases (PI3K) in human, breast-derived cell lines.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/335ea1a5172fc6d0d647e3c40642d987"><gtr:id>335ea1a5172fc6d0d647e3c40642d987</gtr:id><gtr:otherNames>Juvin V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5463715fc2e9c6.13249742</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C98895AE-8021-41ED-9758-8BB320260E94</gtr:id><gtr:title>Characteristics and requirements of basal autophagy in HEK 293 cells.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92e77e76e4cd5d9099b08e357072f4a8"><gtr:id>92e77e76e4cd5d9099b08e357072f4a8</gtr:id><gtr:otherNames>Musiwaro P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>546486810d22b6.77532969</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A577AD69-C2C5-477D-B8F2-DB38D3F91FEE</gtr:id><gtr:title>Stimulating translational research: several European life science institutions put their heads together.</gtr:title><gtr:parentPublicationTitle>Trends in molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8479b792c385ceeaa8f7e0f8f5b7482"><gtr:id>a8479b792c385ceeaa8f7e0f8f5b7482</gtr:id><gtr:otherNames>Bentires-Alj M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-4914</gtr:issn><gtr:outcomeId>56459b1d19cd42.75752579</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C42923B4-97AF-4DDB-8437-27B12CE119F5</gtr:id><gtr:title>In B cells, phosphatidylinositol 5-phosphate 4-kinase-a synthesizes PI(4,5)P2 to impact mTORC2 and Akt signaling.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f24405a6d8b27d5691232d7921709ed0"><gtr:id>f24405a6d8b27d5691232d7921709ed0</gtr:id><gtr:otherNames>Bulley SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>58c67529efaf57.06885335</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31FC9E42-515E-489D-ACE4-0D3BD1780127</gtr:id><gtr:title>Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutations.</gtr:title><gtr:parentPublicationTitle>JCI insight</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/120893d6db842ae2fac96265727b0fb4"><gtr:id>120893d6db842ae2fac96265727b0fb4</gtr:id><gtr:otherNames>Huang-Doran I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2379-3708</gtr:issn><gtr:outcomeId>5a9fb83d27c570.73214690</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64AF49A6-A506-43C5-BEC4-475AC4F439E1</gtr:id><gtr:title>Investigating the effect of arachidonate supplementation on the phosphoinositide content of MCF10a breast epithelial cells.</gtr:title><gtr:parentPublicationTitle>Advances in biological regulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b69f958d0a381f3030849518250d3521"><gtr:id>b69f958d0a381f3030849518250d3521</gtr:id><gtr:otherNames>Anderson KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2212-4926</gtr:issn><gtr:outcomeId>56b0cdd9b2d104.68485968</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>575C5960-DD48-4323-A4DD-3B012A72B699</gtr:id><gtr:title>Inactivation of the Class II PI3K-C2&amp;Icirc;&amp;sup2; Potentiates Insulin Signaling and Sensitivity.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83ed02408872fd806a388ba2a32fb91c"><gtr:id>83ed02408872fd806a388ba2a32fb91c</gtr:id><gtr:otherNames>Alliouachene S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56b0cdd8ca10e9.80705522</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47D98D3E-6A5A-4EDD-B0A4-1AB79777D437</gtr:id><gtr:title>WIPI2 links LC3 conjugation with PI3P, autophagosome formation, and pathogen clearance by recruiting Atg12-5-16L1.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5df1e9d968385276eca1debbe1c09b1a"><gtr:id>5df1e9d968385276eca1debbe1c09b1a</gtr:id><gtr:otherNames>Dooley HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>56e69ba8162dd3.90919712</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>729A0390-1595-47EB-B4E4-887847222573</gtr:id><gtr:title>Live cell imaging of early autophagy events: omegasomes and beyond.</gtr:title><gtr:parentPublicationTitle>Journal of visualized experiments : JoVE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58ff07c4c65556081b629ab8ffec8226"><gtr:id>58ff07c4c65556081b629ab8ffec8226</gtr:id><gtr:otherNames>Karanasios E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1940-087X</gtr:issn><gtr:outcomeId>5464868133de65.73530955</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12BCE50E-FE96-4378-89E9-BAF022FEC561</gtr:id><gtr:title>Dietary restriction protects from age-associated DNA methylation and induces epigenetic reprogramming of lipid metabolism.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d19cda99263b3af807171ba9339d36e0"><gtr:id>d19cda99263b3af807171ba9339d36e0</gtr:id><gtr:otherNames>Hahn O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>5a840bc23adcf6.67265485</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38FD826E-F5C2-4850-BF87-55AD9A86EA11</gtr:id><gtr:title>Monitoring the Localization of MAP1LC3B by Indirect Immunofluorescence.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a519bc60c52f404fb7358caee74f1e3"><gtr:id>8a519bc60c52f404fb7358caee74f1e3</gtr:id><gtr:otherNames>Ktistakis NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1559-6095</gtr:issn><gtr:outcomeId>5aa65ae3e23ad2.03259536</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2D3CD2B-F4B0-4DB0-BF8E-8978BAF6B70D</gtr:id><gtr:title>Regulation of PTEN inhibition by the pleckstrin homology domain of P-REX2 during insulin signaling and glucose homeostasis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc1f03d5e5743d57c8ca238280238cf7"><gtr:id>dc1f03d5e5743d57c8ca238280238cf7</gtr:id><gtr:otherNames>Hodakoski C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>546371602b7893.19726331</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D4F345E-2DC3-42C2-9DDC-0E4D1DDA17C7</gtr:id><gtr:title>The immune system GTPase GIMAP6 interacts with the Atg8 homologue GABARAPL2 and is recruited to autophagosomes.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62306b10204ae9540da023ebeab60ac1"><gtr:id>62306b10204ae9540da023ebeab60ac1</gtr:id><gtr:otherNames>Pascall JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>54648681ce5368.81530254</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F15D1873-6B47-476D-B771-749BF08F8E04</gtr:id><gtr:title>Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress.</gtr:title><gtr:parentPublicationTitle>Cancer cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25501ad3972aae03ba145b3fc728ff6f"><gtr:id>25501ad3972aae03ba145b3fc728ff6f</gtr:id><gtr:otherNames>Schug ZT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1535-6108</gtr:issn><gtr:outcomeId>56af82db52b546.23589070</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4EDCC2AC-B86B-42C7-8C51-0439E73BA8EE</gtr:id><gtr:title>Using lipidomics analysis to determine signalling and metabolic changes in cells.</gtr:title><gtr:parentPublicationTitle>Current opinion in biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9800dd3dc3368924333a50a36d3f896a"><gtr:id>9800dd3dc3368924333a50a36d3f896a</gtr:id><gtr:otherNames>Nguyen A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0958-1669</gtr:issn><gtr:outcomeId>58a1abdc828883.45085119</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21A95A8F-3E3B-4615-9C98-9CA49F0E9B50</gtr:id><gtr:title>WIPI2B links PtdIns3P to LC3 lipidation through binding ATG16L1.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5df1e9d968385276eca1debbe1c09b1a"><gtr:id>5df1e9d968385276eca1debbe1c09b1a</gtr:id><gtr:otherNames>Dooley HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>56e69ba7c71026.30253888</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A83E3EB-6A27-45F6-9F11-539C1CC552B1</gtr:id><gtr:title>In praise of M. Anselmier who first used the term &amp;quot;autophagie&amp;quot; in 1859.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a519bc60c52f404fb7358caee74f1e3"><gtr:id>8a519bc60c52f404fb7358caee74f1e3</gtr:id><gtr:otherNames>Ktistakis NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>5aa65ae38f2ba3.44825315</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1ECFCB9-BF2C-49CB-85C7-E51EECFCB3FC</gtr:id><gtr:title>WIPI2b and Atg16L1: setting the stage for autophagosome formation.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f71e1cd64d74a8f18ba7620e36319531"><gtr:id>f71e1cd64d74a8f18ba7620e36319531</gtr:id><gtr:otherNames>Wilson MI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>56e69ba7e78275.32085795</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4EF48453-F236-4B05-8CA3-56F3259E17D1</gtr:id><gtr:title>Dynamics of mTORC1 activation in response to amino acids.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a58bc4256af610d11eac0d766269b17c"><gtr:id>a58bc4256af610d11eac0d766269b17c</gtr:id><gtr:otherNames>Manifava M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>585d4180033283.58501751</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C6C8AA3-292C-41F6-A3D4-ED193959937C</gtr:id><gtr:title>Correlative Live Cell and Super Resolution Imaging of Autophagosome Formation.</gtr:title><gtr:parentPublicationTitle>Methods in enzymology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43d8fd9101d5b663cce64b14696e0c01"><gtr:id>43d8fd9101d5b663cce64b14696e0c01</gtr:id><gtr:otherNames>Walker SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0076-6879</gtr:issn><gtr:outcomeId>58c6c0263e0345.07634556</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0C1C7E4-7BC3-4D2F-BCBB-5741B5FF6203</gtr:id><gtr:title>The hexosamine biosynthesis pathway and O-GlcNAcylation maintain insulin-stimulated PI3K-PKB phosphorylation and tumour cell growth after short-term glucose deprivation.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4cfff838a1d2c76784b88b2e0a72c01"><gtr:id>f4cfff838a1d2c76784b88b2e0a72c01</gtr:id><gtr:otherNames>Jones DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>5463716097a735.31498019</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F9E0CFD-DF1C-415C-AA9F-32AE0B9043D0</gtr:id><gtr:title>Perturbations of PIP3 signalling trigger a global remodelling of mRNA landscape and reveal a transcriptional feedback loop.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51585f72da0559dba579b0473aa0f917"><gtr:id>51585f72da0559dba579b0473aa0f917</gtr:id><gtr:otherNames>Kiselev VY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>56b0cdd91ead15.09218035</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E59EF832-B2D3-499F-BA69-2F6A722FEED0</gtr:id><gtr:title>Dynamic association of the ULK1 complex with omegasomes during autophagy induction.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58ff07c4c65556081b629ab8ffec8226"><gtr:id>58ff07c4c65556081b629ab8ffec8226</gtr:id><gtr:otherNames>Karanasios E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>5464868182c0f5.37098171</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C1B95DB-DA61-48E5-ABA9-B261CF145BC7</gtr:id><gtr:title>The role of MAPK signalling pathways in the response to endoplasmic reticulum stress.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6729b387bf4e554c2fee167548dc24df"><gtr:id>6729b387bf4e554c2fee167548dc24df</gtr:id><gtr:otherNames>Darling NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>546f510a42e8f6.55054748</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37E11F3D-3739-4684-96F8-ACEAC5FAB91F</gtr:id><gtr:title>The cytotoxic T cell proteome and its shaping by the kinase mTOR.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eef98c48a65d8829114d02004207fa4a"><gtr:id>eef98c48a65d8829114d02004207fa4a</gtr:id><gtr:otherNames>Hukelmann JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>56b0cdd981a655.98173046</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BCEB109-87B3-4EB6-AD36-B14D2029DD2D</gtr:id><gtr:title>Molecular definitions of autophagy and related processes.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f446e86d6836d8e6a5da49dfe563b87"><gtr:id>8f446e86d6836d8e6a5da49dfe563b87</gtr:id><gtr:otherNames>Galluzzi L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>5aa65b9f146ba8.88739901</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A19F7793-04EF-4DD7-AD57-14FEA12648BC</gtr:id><gtr:title>Dynamics of autophagosome formation: a pulse and a sequence of waves.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a519bc60c52f404fb7358caee74f1e3"><gtr:id>8a519bc60c52f404fb7358caee74f1e3</gtr:id><gtr:otherNames>Ktistakis NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>54648682250516.80095407</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEC871BD-AD06-492F-8888-8E857ACBB4BC</gtr:id><gtr:title>ERK1/2 signalling protects against apoptosis following endoplasmic reticulum stress but cannot provide long-term protection against BAX/BAK-independent cell death.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6729b387bf4e554c2fee167548dc24df"><gtr:id>6729b387bf4e554c2fee167548dc24df</gtr:id><gtr:otherNames>Darling NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a2fcd7910fd29.87826548</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E1893DD-3568-4F7D-A129-37BCADAEF38B</gtr:id><gtr:title>Phospholipase D activity couples plasma membrane endocytosis with retromer dependent recycling.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/667dc2b19e6a4b459ef3c0c7e98ccd94"><gtr:id>667dc2b19e6a4b459ef3c0c7e98ccd94</gtr:id><gtr:otherNames>Thakur R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>58c6c026751314.88524592</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A10A3D01-19F7-4728-B6DD-086EA41953F2</gtr:id><gtr:title>PTEN mutations as a cause of constitutive insulin sensitivity and obesity.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5b0014925c78d1f72d48bc09ae442a2"><gtr:id>b5b0014925c78d1f72d48bc09ae442a2</gtr:id><gtr:otherNames>Pal A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>546489ab61b6a4.50974691</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70BAE4A2-3E31-4437-B4EB-2B7699CBB231</gtr:id><gtr:title>Autophagy initiation by ULK complex assembly on ER tubulovesicular regions marked by ATG9 vesicles.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58ff07c4c65556081b629ab8ffec8226"><gtr:id>58ff07c4c65556081b629ab8ffec8226</gtr:id><gtr:otherNames>Karanasios E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>58c6c026af9ec1.50651972</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9FE4530-4BB2-49D3-87D2-D81B592DD42B</gtr:id><gtr:title>PIPing on lysosome tubes.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a519bc60c52f404fb7358caee74f1e3"><gtr:id>8a519bc60c52f404fb7358caee74f1e3</gtr:id><gtr:otherNames>Ktistakis NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>54648680da8381.91715796</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5EBF9C6-ADA7-47C0-B769-3A6C8BF04371</gtr:id><gtr:title>Adaptation to mTOR kinase inhibitors by amplification of eIF4E to maintain cap-dependent translation.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c74644e7b4455a2471cfce5f4a2f7eb"><gtr:id>0c74644e7b4455a2471cfce5f4a2f7eb</gtr:id><gtr:otherNames>Cope CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>546f510a0ccfd9.20697497</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BBS/E/B/000C0413</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>